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ABSTRACT 
Dengue is the most common mosquito-borne viral infection worldwide. There is increased evidence for dengue virus 
neurotropism, and neurological manifestations could make part of the clinical picture of dengue virus infection. Pathogenic 
mechanisms include systemic complications and metabolic disturbances resulting in encephalopathy, direct effect of the virus 
provoking encephalitis, and post infectious immune mechanisms causing immune-mediated syndromes. Dengue viruses should 
be considered as a cause of neurological disorders in endemic regions. Standardized case definitions for specific neurological 
complications are still needed. We report a patient with dengue fever who later developed bilateral facial nerve palsy. 
Keywords: Dengue, Facial nerve palsy, Infection 
 
engue is an acute viral infection with potential 
fatal complications. Dengue viruses (DV) belong 
to family Flaviviridae and there are four 
serotypes of the virus referred to as DV-1, DV-2, DV-3 
and DV-4. It is transmitted mainly by Aedes aegypti 
mosquito and also by Ae. albopictus. All four serotypes 
can cause the full spectrum of disease from a subclinical 
infection to a mild self limiting disease, the dengue fever 
(DF) and a severe disease that may be fatal, the dengue 
haemorrhagic fever/dengue shock syndrome (DHF/DSS). 
Recently, neurological manifestations have been 
increasingly described in dengue fever, making it 
challenging to correlate neurological symptoms to the 
infection [1]. The incidence of infection associated to 
neurological manifestations ranges from 1% to 5% [2-3]. 
The most common neurological presentations are 
encephalitis and encephalopathy, although every year 
cases of meningitis, Guillain-Barré syndrome (GBS), 
myelitis, acute disseminated encephalomyelitis, acute  
 
motor weakness, myositis, neuritis and neuropathy have 
been reported [4-6]. DENV-2 and DENV-3 serotypes are 
most frequently associated with neurological 
complications [7-9]. Immunoreactivity to DENV-4 has 
also been detected in neurons, microglia and endothelial 
cells [10]. The role of viral factors in dengue 
neuropathogenesis was demonstrated by mutating three 
amino acids in DENV-1, mapping to the structural protein 
E and non-structural protein NS3 helicase domains. These 
mutations produced a neurovirulent virus, and the result 
was an extensive encephalitis and leptomeningitis in mice 
[11]. 
Analysis of CSF contributes to the neurological 
diagnosis associated with dengue by the demonstration of: 
i) inflammatory reaction in the CNS (pleocytosis, 
hyperproteinorhachia, blood-CSF barrier dysfunction, and 
intrathecal synthesis of total IgG) in cases of encephalitis, 
myelitis, and meningitis; ii) protein-cytological 
dissociation in Guillain Barré syndrome; iii) hemorrhagic 
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CSF in cases of cerebromeningeal hemorrhage; iv) 
exclusion of other infectious diseases; and v) detection of 
specific antibodies and viral antigens [12-14]. However, 
normal CSF does not exclude the possibility of 
neurological complications associated with dengue. 
CASE REPORT 
A 41 year old man presented with complaints of high 
grade fever, myalgia, arthralgia, retro orbital burning pain, 
abdominal pain, weakness and anorexia of 5 days duration. 
On evaluation, patient was haemodynamically stable with 
a blood pressure of 110/74 mm-Hg, pulse rate of 96/min. 
He had high grade fever with maximum temperature up to 
104
0
 F. His laboratory parameters showed leucopoenia 
(4300/mm
3
), thrombocytopenia (71000/mm
3
) and liver 
function tests showed elevated transaminases (AST/ALT 
104/55 IU/L). Dengue serology showed positive NS1 
antigen test while chikungunya serology was negative and 
rest of the investigations were within normal limits. Patient 
was diagnosed with dengue fever, managed conservatively 
and discharged in a stable condition after three days of in 
hospital care. Platelet count at discharge was 
1.25lakh/mm
3 
and patient was afebrile. 
One week after discharge patient started having 
difficulty in speaking, chewing and inability to close eyes 
along with recurrence of myalgia and arthralgia. On 
evaluation, patient was having normal higher mental 
functions; although, he had bilateral lower motor neurone 
facial palsy, his upper and lower limb muscles had a power 
of grade 4+, deep tendon reflexes were normal with no 
sensory deficits, babinski was bilateral flexor response 
with no cerebellar signs. 
On investigations, serum potassium level was 4.1 
mEq/L, CSF analysis revealed no cells with normal 
glucose level (69.8mg/dl, corresponding plasma glucose- 
84.9mg/dl), raised protein (113.94mg/dl) and normal gram 
stain, india ink and CSF culture. CSF was also evaluated 
using ELISA based kit for dengue and was found to be 
IgM positive. His MRI brain was normal and MRI cervical 
spine showed mild edema along superior end plate of C5 
vertebra. Patient subsequently underwent nerve conduction 
study which was suggestive of symmetrical, 
predominantly motor, predominantly axonal 
polyneuropathy. Patient was subsequently started on 
intravenous methylprednisolone 1 gm OD over 5 days. 
Patient showed improvement in muscle power and was 
subsequently discharged in stable condition. He was doing 
normal on follow up at 1 month of discharge. 
DISCUSSION 
Dengue viruses now affect almost every country between 
the tropics. Neurological manifestations received little 
attention initially, but in the last twenty years there has 
been increasing recognition of their possible importance. 
Neurological findings reported in association with dengue 
include mononeuropathies, polyneuropathies, and 
Guillain-Barré syndrome. The patient in our case had a 
motor axonal polyneuropathy. He had high grade fever, 
headache, arthralgia, retroorbital burning and myalgia 
during the acute presentation, which were consistent with 
an acute dengue, and this was supported by the positive 
serology (NS1 Ag). There have been many other case 
reports of dengue infection associated with CNS 
involvement. A case was reported from Jamaica of a 51 
year old man with dengue fever who presented with 
encephalopathy, cranial nerve palsy, and severe hepatitis 
[15]. Diagnosis of neurological dengue needs to be 
revaluated; especially for clinicians, who are unfamiliar 
with its wide array of clinical presentations. 
Diagnosis is currently based on the detection of 
specific IgM antibodies or antigens in the blood. In 
addition, analysis of CSF (for the detection of specific 
antibodies and viral antigens) has demonstrated great 
potential as a diagnostic tool for neurological dengue as 
well as for providing a better understanding of the dengue 
neuropathogenesis. In endemic areas or in cases of recent 
travel to endemic regions, dengue infection should be 
considered in the differential diagnosis of encephalitis, 
myelitis, Guillain-Barrè syndrome, and meningitis, even in 
the absence of a previous history of dengue fever. The 
neurological complications associated with dengue may be 
underestimated, especially in cases in which there was a 
prior asymptomatic dengue infection. Improving the 
accuracy of diagnosis is important for the early treatment 
of the neurological complications, thereby avoiding 
unnecessary therapy and longer hospitalization, while 
searching for the presence of other diseases. 
CONCLUSION 
Our case highlights the importance of high index of 
suspicion to diagnose neurological involvement of dengue 
infection. It should be considered in the differential 
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diagnosis of encephalitis, myelitis, Guillain-Barrè 
syndrome, and meningitis, even in the absence of a 
previous history of dengue fever. 
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